Strategic Initiative

Slingshot members are tracking this corporate initiative:

Volpi Group partners with QIAGEN to manufacture the imaging module for the GeneReader NGS platform

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
QGEN

100%
Volpi Group

100%

Additional Information

Additional Relevant Details Volpi group is collaborating with QIAGEN Instruments AG on the manufacture of the automated fluorescence imaging module used in QIAGEN’s GeneReaderTM next-generation sequencing (NGS) instrument. The benchtop GeneReader combines with other QIAGEN NGS products to provide the first seamless, fully automated Sample to Insight workflow.Volpi optimized the GeneReader’s automated imaging module at its precision engineering site in Zurich, Switzerland. The module for the QIAGEN instrument is manufactured at Volpi’s production facility in Auburn, N.Y., U.S.A. Volpi specializes in the engineering and manufacture of optoelectronic modules for diagnostic, life science and other applications. These modules combine electronics with the detection and measurement of light, like the fluorescent light emitted by the GeneReader system when a biological marker is present in a patient sample.
https://www.volpi.ch...
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Feb 08, 2016
Projected Implementation:
Q1, 2016
Relevance Tracked Until:
Q4, 2016
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Qiagen, Genereader, Ngs Platform